A detailed history of Flossbach Von Storch Ag transactions in Amgen Inc stock. As of the latest transaction made, Flossbach Von Storch Ag holds 753 shares of AMGN stock, worth $234,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares
753
Holding current value
$234,092
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$268.87 - $324.56 $202,459 - $244,393
753 New
753 $214,000
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $2.76 Million - $3.29 Million
-12,760 Closed
0 $0
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $530,130 - $650,543
-2,680 Reduced 17.36%
12,760 $3.01 Million
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $2 Million - $2.65 Million
10,950 Added 243.88%
15,440 $3.13 Million
Q4 2019

Feb 11, 2020

SELL
$189.21 - $243.2 $8.44 Million - $10.8 Million
-44,600 Reduced 90.85%
4,490 $1.08 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $87,055 - $104,310
500 Added 1.03%
49,090 $9.5 Million
Q2 2019

Aug 06, 2019

BUY
$166.7 - $195.41 $56,677 - $66,439
340 Added 0.7%
48,590 $8.95 Million
Q1 2019

May 02, 2019

BUY
$180.87 - $203.88 $578,784 - $652,416
3,200 Added 7.1%
48,250 $9.17 Million
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $135,227 - $157,853
-758 Reduced 1.65%
45,050 $8.77 Million
Q3 2018

Nov 05, 2018

SELL
$185.29 - $208.89 $3.65 Million - $4.12 Million
-19,700 Reduced 30.07%
45,808 $9.5 Million
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $896,670 - $1.01 Million
5,400 Added 8.98%
65,508 $12.1 Million
Q1 2018

May 04, 2018

SELL
$169.43 - $198.0 $12.1 Million - $14.1 Million
-71,292 Reduced 54.26%
60,108 $10.2 Million
Q4 2017

Feb 07, 2018

SELL
$168.79 - $188.59 $35.9 Million - $40.1 Million
-212,870 Reduced 61.83%
131,400 $22.9 Million
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $57.6 Million - $65.8 Million
344,270
344,270 $64.2 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Flossbach Von Storch Ag Portfolio

Follow Flossbach Von Storch Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flossbach Von Storch Ag, based on Form 13F filings with the SEC.

News

Stay updated on Flossbach Von Storch Ag with notifications on news.